Ironwood Pharma (NASDAQ:IRWD)

OklaBoston (< 20) Submitted: 5/13/2013 11:50:27 AM : Start Price: $14.25 IRWD Score: +7.93

Debt levels, insider selling and absurd P/Book say this is going back to 1 Star status soon.

zzlangerhans (99.79) Submitted: 5/10/2013 3:06:17 AM : Start Price: $14.40 IRWD Score: -11.82

If it was just me, I probably wouldn't green thumb Ironwood just yet and I definitely wouldn't be buying into this launch. But now I'm working with Portefeuille and his word is law, and he wanted 300 shares at 14.72. There's no question that linaclotide has potential, but falling knife stocks that are navigating drug launches are not my personal style. As usual, I expect my reticence to be proven wrong.

MicroMagic (57.59) Submitted: 9/23/2012 11:10:12 AM : Start Price: $14.32 IRWD Score: +22.47

New constipation and irritable bowel syndrom drug gets EC approval.

EC approved laxative?

I don't see why the stock is valued at $1.5 billion.

Gordon024 (57.71) Submitted: 9/4/2012 3:35:52 PM : Start Price: $12.51 IRWD Score: -13.28

FDA approval of new IBS drug. IBS sufferers have been waiting for this drug and following the FDA approval process in anticipation of it's release.

bustoff (< 20) Submitted: 9/3/2012 12:10:12 AM : Start Price: $12.61 IRWD Score: -14.13

was the drug approval noticed by anyone?

Micrx (< 20) Submitted: 7/11/2012 9:22:05 AM : Start Price: $13.57 IRWD Score: -27.30

PDUFA date in next couple months. Drugs has a huge market with less effective competition.

SamsaricSufferer (< 20) Submitted: 7/4/2012 8:35:17 PM : Start Price: $13.97 IRWD Score: -27.62

PDUFA coming up

portefeuille (99.78) Submitted: 12/16/2011 12:11:22 AM : Start Price: $12.72 IRWD Score: -34.70

There are currently 2100 IRWD shares in my "fund" with break-even of around 7.48 USD. http://caps.fool.com/Blogs/fund-trades/678775.

BullDozeR2121 (< 20) Submitted: 11/2/2011 11:25:38 AM : Start Price: $11.91 IRWD Score: -15.00

With recent Phase 3 FDA testing of their linaclotide drug that has a proven track record resulting in positive performance and a $20bb potential market coupled with no competition (that is until Synergy Pharmaceuticals SGYP drug comes to market), I see tremendous upside in this Bio-tech over the next couple of years.

lonewulf47638 (61.46) Submitted: 3/16/2010 9:25:04 AM : Start Price: $14.00 IRWD Score: +49.67

Another pharm with no earnings.